ClinicalTrials.gg
RecruitingNCT06389435ROCKETSUpdated Sep 21, 2026

RObotic-assisted Versus Conventional Knee Endoprosthetic Techniques

An interventional study of Robot-assisted total knee arthroplasty and Conventional total knee arthroplasty in Knee Arthroplasty, Total, Robotic-assisted and Osteoarthritis of the Knee, sponsored by Danderyd Hospital. Recruiting at 2 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Danderyd Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,600
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 54 studies in Osteoarthritis, Knee with a site in Sweden — 12 open to participants now, 19 under way, none of them phase 3. Osteoarthritis, Knee · Sweden.

Planned enrollment
2nd of 38
1,600 · median 175
Started
2024
with 4 others
No phase
23 of 54
7 open now
Primary completion
2029-12
later than 15 of 18 live
Registered
44th of 54
by date

Among the 54 studies in Osteoarthritis, Knee with a site in Sweden, this one is the 2nd largest by planned enrollment of the 38 interventional ones that give a count, is one of 5 that started in 2024, is one of 23 with no phase, reaches primary completion later than 15 of the 18 other live ones, and was the 44th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

12 of the 54 studies in Osteoarthritis, Knee with a site in Sweden are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Osteoarthritis, Knee with a site in Sweden, or all of them as a file.
02

Study summary

Rationale for conducting the study:

The ROCKET study evaluates the clinical and economic outcomes of robot-assisted total knee arthroplasty (RTKR) compared with conventional total knee arthroplasty (TKR). The primary endpoint is the proportion of randomized participants achieving a Forgotten Joint Score (FJS) of ≥80 points at 24 months after surgery. Secondary outcomes include patient-reported knee function, health-related quality of life, self-reported instability, physical activity, radiographic alignment, surgical and technical outcomes, complications, reoperations, revisions, and health-economic outcomes.

Study design:

International multicentre, preference-tolerant, randomized, controlled superiority trial with two treatment arms comparing RTKR with conventional TKR. Participants in the randomized part are allocated 1:1. At selected centres where feasible, an optional participant-blinded randomized component may be implemented. Eligible patients who do not undergo randomization may participate in a parallel observational/preference cohort, which is analysed separately from the primary randomized comparison.

Study population:

Adults aged 18 years and older who are eligible for total knee arthroplasty according to local guidelines and who provide informed consent.

Number of patients:

Up to 1,600 randomized participants. Eligible non-randomized participants may additionally be included in the observational/preference cohort.

Primary outcome:

Proportion of randomized participants achieving FJS ≥80 points at 24 months after surgery.

Long-term follow-up:

Patient-reported and registry-based outcomes are planned at 5 and 10 years after surgery where feasible.

Read the detailed description

The ROCKET study is an international multicentre, prospective, preference-tolerant randomized controlled superiority trial comparing robot-assisted total knee arthroplasty with conventional total knee arthroplasty.

Participants in the randomized component are allocated 1:1 to robot-assisted or conventional total knee arthroplasty. Randomization is stratified by participating centre and sex. At selected centres where practical and approved, participants may remain blinded to treatment allocation until completion of the 24-month follow-up unless earlier unblinding is clinically required or requested by the participant. Surgeons and operating-room personnel cannot be blinded. Outcome assessment is performed blinded to treatment allocation whenever feasible.

Eligible patients who are unwilling to undergo randomization, or for whom treatment equipoise cannot be achieved, may enter a parallel observational/preference cohort. Treatment in this cohort follows patient and surgeon preference. The observational/preference cohort is analysed separately from the primary randomized comparison.

The primary endpoint is the proportion of randomized participants achieving a Forgotten Joint Score (FJS) of ≥80 points at 24 months after surgery. Follow-up includes patient-reported outcomes, activity, radiographic alignment, surgical and technical variables, complications, reoperations, revisions and health-economic outcomes. Long-term follow-up is planned at 5 and 10 years after surgery, including PROMs where available and registry-based outcomes such as reoperations, revisions, complications and mortality.

03

Conditions studied

  • Knee Arthroplasty, Total
  • Robotic-assisted
  • Osteoarthritis of the Knee

Keywords

  • Knee arthroplasty
  • Robotic assisted
  • Osteoartritis
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years and older.
  • Eligible for total knee arthroplasty according to local guidelines and routines.
  • Willingness to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Patients with extreme malalignment necessitating special implants or techniques.
  • Patients unfit for surgery due to other medical reasons.
  • Patients who, for other reasons such as alcohol or substance abuse, are deemed unsuitable to participate in the study.
  • Patients who, for other reasons, cannot fulfil the required patient-reported outcome measures.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
1,600 participants (estimated)

Study arms

  • Experimental
    RTKR

    Robot-assisted total knee arthroplasty (RTKR).

    Procedure: Robot-assisted total knee arthroplasty

  • Active comparator
    TKR

    Conventional total knee arthroplasty (TKR).

    Procedure: Conventional total knee arthroplasty

Interventions

  • ProcedureRobot-assisted total knee arthroplasty

    Robot-assisted total knee arthroplasty using an approved robotic surgical system to assist intraoperative planning, bone preparation, implant positioning and balancing according to the participating centre's approved technique.

  • ProcedureConventional total knee arthroplasty

    Conventional total knee arthroplasty using standard manual instrumentation according to local clinical routine.

06

What researchers measure

Primary outcomes

  1. Proportion of participants achieving a Forgotten Joint Score (FJS) ≥80 points

    The primary endpoint is the proportion of randomized participants achieving an FJS of ≥80 points at 24 months after surgery. The FJS ranges from 0 to 100, with higher scores indicating less awareness of the replaced knee during everyday activities.

    Time frame: 24 months after surgery

Secondary outcomes

  1. Forgotten Joint Score (FJS), continuous score

    FJS is scored from 0 to 100, with higher scores indicating less awareness of the replaced knee.

    Time frame: Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

  2. Knee injury and Osteoarthritis Outcome Score (KOOS)

    KOOS assesses knee-related pain, symptoms, activities of daily living, sport/recreation and knee-related quality of life. Each subscale ranges from 0 to 100, with higher scores indicating better outcome.

    Time frame: Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

  3. Self-reported knee instability (ADLS items)

    Self-reported slipping/partial giving way and buckling/full giving way are assessed using items from the Activities of Daily Living Scale of the Knee Outcome Survey.

    Time frame: Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

  4. EQ-5D and EQ VAS

    Health-related quality of life is assessed using EQ-5D and EQ VAS.

    Time frame: Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

  5. Patient activity and walking distance

    Patient activity and walking distance are assessed during follow-up using the study's prespecified activity measurements.

    Time frame: Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

  6. Knee alignment

    Coronal knee alignment is assessed using long-standing radiographs, including Hip-Knee-Ankle alignment and Coronal Plane Alignment of the Knee (CPAK) classification.

    Time frame: Preoperative and approximately 6 weeks after surgery

  7. Surgery time

    Duration of the surgical procedure is recorded in minutes.

    Time frame: During the index operation

  8. Technical and intraoperative surgical outcomes

    Technical difficulties and prespecified intraoperative surgical details are recorded.

    Time frame: During the index operation

  9. Range of motion (ROM)

    Knee range of motion is assessed at the 24-month follow-up.

    Time frame: 24 months after surgery

  10. Reoperations and revisions

    Reoperations and revisions of the index knee are recorded during the primary study period and assessed during long-term follow-up where data are available.

    Time frame: Up to 24 months, with additional follow-up at 5 and 10 years

  11. Adverse events and complications

    Adverse events and complications related to the index knee arthroplasty are recorded. Long-term complications may additionally be assessed using approved registry or other data sources.

    Time frame: Up to 24 months, with additional long-term assessment at 5 and 10 years

  12. Mortality

    Mortality is assessed using available approved registry or other data sources.

    Time frame: 90 days, 1 year, 5 years and 10 years after surgery

  13. Health-economic outcomes

    Health-economic analyses include direct and indirect costs and cost-effectiveness using health-related quality-of-life data.

    Time frame: Up to 24 months; exploratory long-term analyses at 5 and 10 years where data are available

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Dec 2029, 69 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 69 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 4, 2024
First posted
Apr 29, 2024
StartActual
Mar 4, 2024
Primary completionEst.
Dec 2029
CompletionEst.
Dec 2037
Last update
Sep 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06389435
Lead sponsor
Danderyd Hospital
Responsible party
Olof Skoldenberg (Professor, Danderyd Hospital) — Principal investigator
First posted
Apr 29, 2024
Start date
Mar 4, 2024
Primary completion
Dec 2029 (estimated)
Completion
Dec 2037 (estimated)
Last update
Sep 21, 2026

Study contacts

Olof Sköldenberg, MD, PhD
Contact
olof.skoldenberg@ki.se
46+700891253

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion